首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷內視鏡檢查設備

市場調查報告書

商品編碼

1477914

機器人內視鏡設備市場 - 按產品類型（診斷、治療）、應用（大腸鏡檢查、支氣管鏡檢查、腹腔鏡檢查、胃鏡檢查）、最終用途（醫院、門診手術中心） - 全球預測，2024 - 2032

Robotic Endoscopy Devices Market - By Product Type (Diagnostic, Therapeutic), Application (Colonoscopy, Bronchoscopy, Laparoscopy, Gastroscopy), End-use (Hospitals, Ambulatory Surgical Centers) - Global Forecast, 2024 - 2032

出版日期: 2024年02月22日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

受人口老齡化人口成長和導致慢性病增加的生活方式因素變化的推動，全球機器人內視鏡設備行業在 2024 年至 2032 年期間將以 11% 的複合年成長率成長。

據世界衛生組織稱，非傳染性疾病（NCD）每年奪走 4,100 萬人的生命，佔全球死亡人數的 74%。隨著全球人口老化和生活方式的演變，糖尿病、心血管疾病、癌症和呼吸系統疾病等慢性病的發生率持續上升。這種人口結構的變化意味著對有效管理這些疾病的創新療法、療法和預防措施的需求增加。

因此，醫療保健產業的研發投資正在激增，導致針對特定慢性疾病的新型藥物、醫療設備和數位健康解決方案的發現。此外，人們越來越重視旨在減少與慢性病相關的風險因素的預防性醫療保健計劃、健康計劃和生活方式干涉措施。此外，遠距醫療、穿戴式裝置和健康監測應用程式等技術突破正在徹底改變患者護理，並使個人能夠積極管理自己的健康。

機器人內視鏡設備市場根據產品類型、應用、最終用途和地區進行分類。

診斷機器人內視鏡設備細分市場將在 2032 年大幅成長，因為它們能夠提供高清成像、精確的組織採樣和內臟的即時視覺化。這些設備有助於早期發現和準確診斷各種胃腸道和呼吸系統疾病，包括潰瘍、息肉、腫瘤和發炎性腸道疾病，從而誘導節段生長。

由於支氣管鏡檢查廣泛用於診斷和治療肺癌、慢性阻塞性肺病 (COPD) 和肺纖維化等呼吸系統疾病，到 2032 年，支氣管鏡檢查領域的機器人內視鏡設備市場佔有率將獲得成長。機器人支氣管鏡使臨床醫生能夠以增強的可操作性和靈活性來導航複雜的氣道解剖結構，從而促進精確的病灶定位、活體組織切片採集和治療干預，從而推動肺段擴張。

在醫療保健基礎設施快速擴張以及醫療技術投資不斷增加的推動下，亞太地區機器人內視鏡設備產業預計到 2032 年將大幅成長。此外，中國、印度和日本等國家呼吸系統疾病的盛行率不斷上升，推動了機器人內視鏡設備用於診斷和治療目的的採用。

產業生態系統分析
產業影響力
- 成長動力
  - 胃腸道疾病和其他慢性疾病的發生率上升
  - 微創手術的需求不斷增加
  - 肥胖和糖尿病盛行率上升，人口老化加劇
  - 內視鏡技術的進步
- 產業陷阱與挑戰
  - 發展中國家缺乏熟練的醫生和內視鏡醫師
成長潛力分析
監管環境
技術景觀
波特的分析
PESTEL分析
未來市場趨勢

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品類型，2018 年 - 2032 年

主要趨勢
診斷
治療性

第 6 章：市場估計與預測：按應用分類，2018 年 - 2032 年

主要趨勢
大腸鏡檢查
支氣管鏡檢查
腹腔鏡檢查
胃鏡
其他應用

第 7 章：市場估計與預測：按最終用途，2018 - 2032 年

主要趨勢
醫院
門診手術中心
其他最終用戶

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

AKTORmed GmbH
Asensus Surgical Inc.
Boston Scientific Corporation
Brainlab AG
CONMED Corporation
FUJIFILM Holdings Corporation
Intuitive Surgical, Inc.
Karl Storz SE & Co. KG
Medtronic plc
Olympus Corporation
Renishaw plc
Richard Wolf GmbH

簡介目錄

Product Code: 8222

Global Robotic Endoscopy Devices Industry will grow at 11% CAGR during 2024-2032, driven by the growing aging population demographics and changing lifestyle factors contributing to the rise in chronic conditions.

According to WHO, Noncommunicable diseases (NCDs) claim the lives of 41 million people annually, accounting for 74% of global deaths. As global populations age and lifestyles evolve, the incidence of chronic conditions such as diabetes, cardiovascular diseases, cancer, and respiratory ailments continues to rise. This demographic shift translates into heightened demand for innovative treatments, therapies, and preventive measures to manage these conditions effectively.

Consequently, the healthcare sector is experiencing a surge in R&D investments, leading to the discovery of novel drugs, medical devices, and digital health solutions tailored to address specific chronic diseases. Additionally, there is a growing emphasis on preventive healthcare initiatives, wellness programs, and lifestyle interventions aimed at reducing the risk factors associated with chronic illnesses. Moreover, technological breakthroughs, such as telemedicine, wearable devices, and health monitoring apps, are revolutionizing patient care and empowering individuals to actively manage their health.

The Robotic Endoscopy Devices Market is classified based on product type, application, end-use, and region.

The diagnostic robotic endoscopy devices segment will grow appreciably through 2032, owing to their ability to provide high-definition imaging, precise tissue sampling, and real-time visualization of internal organs. These devices help in the early detection and accurate diagnosis of various gastrointestinal and respiratory conditions, including ulcers, polyps, tumors, and inflammatory bowel diseases, thereby inducing segment growth.

The Robotic Endoscopy Devices Market share from the bronchoscopy segment will gain traction by 2032 due to the widespread use of bronchoscopy in diagnosing and treating respiratory disorders such as lung cancer, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. Robotic bronchoscopy enables clinicians to navigate the intricate airway anatomy with enhanced maneuverability and dexterity, thus facilitating precise lesion localization, biopsy collection, and therapeutic interventions, thereby propelling segment expansion.

Asia Pacific Robotic Endoscopy Devices Industry is poised for substantial growth by 2032, driven by a rapidly expanding healthcare infrastructure, in line with increasing investments in medical technology. Additionally, the rising prevalence of respiratory diseases in countries such as China, India, and Japan is boosting the adoption of robotic endoscopy devices for both diagnostic and therapeutic purposes.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidences of gastrointestinal disorders and other chronic ailments
  - 3.2.1.2 Increasing demand for minimally invasive procedures
  - 3.2.1.3 Rise in prevalence of obesity and diabetes coupled with growing ageing population
  - 3.2.1.4 Technological advancements in endoscopy
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Dearth of skilled physicians and endoscopists in developing countries
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis
3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Diagnostic
5.3 Therapeutic

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Colonoscopy
6.3 Bronchoscopy
6.4 Laparoscopy
6.5 Gastroscopy
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa